Interim clinical trial results show promise in the treatment of Acute Promyelocytic Leukaemia (APL)June 28, 2019As part of the EHA conference, Prof Harry Iland launched the APML5 interim clinical trial results, a comparative bioavailability study [...]
May 2019 ALLG Scientific Meeting HighlightsMay 31, 2019The Australasian Leukaemia and Lymphoma Group (ALLG) held its May 2019 Scientific Meeting (SM) in Sydney with over 300 members, [...]
AML in 2019 and BeyondApril 30, 2019On 21 March 2019, the ALLG in conjunction with the VCCC hosted ‘AML in 2019 and Beyond’ at Walter and Eliza Hall Institute of Medical [...]
MRFF Supporting ALLG Clinical ResearchersMarch 29, 2019Last year, the Liberal National Government announced that they will provide $38.6 million to support 23 new clinical trials to improve [...]
Welcoming Marina Mullins, ALLG Operations ManagerFebruary 21, 2019Late last year, the ALLG appointed Marina Mullins in the role of ALLG Operations Manager. She manages both the programme of ALLG [...]
Vale Professor Bertrand CoiffierJanuary 7, 2019We are all extremely saddened to announce that internationally renowned and respected Professor Bertrand Coiffier passed away on 2 [...]
2018, A Year in ReviewDecember 7, 2018This year, ALLG achieved an increase in the number and participation of clinical trials, an increase in member engagement, and improved [...]
November 2018 ALLG Scientific Meeting HighlightsNovember 29, 2018The Australasian Leukaemia and Lymphoma Group (ALLG) held its November 2018 Scientific Meeting (SM) in Brisbane with 111 members in [...]
Australasian Leukaemia and Lymphoma Group is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity.
Memberships
Donations
Clinical Trials & Research